Drugs / PTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01737216 Comparator | Nov 2012 → Jan 2016 | lung cancer | Hebei Tumor Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PTX | “TP(PTX 135-175mg/m2 d1;DDP 60-75mg/m2 d1)” NCT01737216 ↗ |